Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.

[1]  D. Crowther,et al.  Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma. , 1990, Annals of Oncology.

[2]  D. Crowther,et al.  Original article: Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma , 1990 .

[3]  D. Crowther,et al.  Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. , 1988, European journal of cancer & clinical oncology.

[4]  S. Howell,et al.  Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Markman,et al.  Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. , 1986, Cancer treatment reviews.

[6]  Morgan Lr.  Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. , 1985 .

[7]  S. Howell,et al.  Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Olshen,et al.  Intraperitoneal cisplatin with systemic thiosulfate protection. , 1982, Annals of internal medicine.

[9]  R. Ozols,et al.  Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer , 1982, Cancer research.

[10]  S. Howell,et al.  Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. , 1981, The Journal of clinical investigation.

[11]  P. Schwartz,et al.  Second-look operations in ovarian cancer. , 1980, American journal of obstetrics and gynecology.

[12]  J. Mcvie,et al.  Experimental and clinical status of intraperitoneal chemotherapy. , 1990, European journal of cancer.

[13]  V. Devita,et al.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. , 1978, Cancer treatment reports.